PATENT CLAIM ANALYSIS

Application Number: 16321141
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["424", "218100"]

Abstract:
The invention relates to a Zika viral vector vaccine comprising nucleic acid encoding a Zika virus structural antigen, wherein the nucleic acid encoding a Zika virus structural antigen comprises a sequence encoding Zika virus envelope DIII, or part thereof. The invention further relates to a Zika viral vector vaccine in combination with a Chikungunya viral vector vaccine.

Claim (Index 4):
The Zika viral vector vaccine according to any preceding claim, wherein the nucleic acid encoding the Zika virus structural antigen comprises or consists of the sequence of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 99.0
- Lexical Diversity: 1.90625
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16099254', '16009811', '15674585', '16136386', '15212804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7694622963869492
- 35 USC 102 Novelty (BERT): 0.5722671917844679
- Combined Prediction Score: 0.7497427859267011
- Mean Citation Score: 435.93444199999993
- Max Citation Score: 469.0889
- Similarity Product: 365.45818727202425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test